Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.
Terpos E, Trougakos IP, Apostolakou F, Charitaki I, Sklirou AD, Mavrianou N, Papanagnou ED, Liacos CI, Gumeni S, Rentziou G, Korompoki E, Papassotiriou I, Dimopoulos MA. Terpos E, et al. Among authors: apostolakou f. Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24. Am J Hematol. 2021. PMID: 33837984 Free PMC article. No abstract available.
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.
Bergamaschi C, Terpos E, Rosati M, Angel M, Bear J, Stellas D, Karaliota S, Apostolakou F, Bagratuni T, Patseas D, Gumeni S, Trougakos IP, Dimopoulos MA, Felber BK, Pavlakis GN. Bergamaschi C, et al. Among authors: apostolakou f. Cell Rep. 2021 Aug 10;36(6):109504. doi: 10.1016/j.celrep.2021.109504. Epub 2021 Jul 23. Cell Rep. 2021. PMID: 34352226 Free PMC article.
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
Trougakos IP, Terpos E, Zirou C, Sklirou AD, Apostolakou F, Gumeni S, Charitaki I, Papanagnou ED, Bagratuni T, Liacos CI, Scorilas A, Korompoki E, Papassotiriou I, Kastritis E, Dimopoulos MA. Trougakos IP, et al. Among authors: apostolakou f. BMC Med. 2021 Aug 23;19(1):208. doi: 10.1186/s12916-021-02090-6. BMC Med. 2021. PMID: 34420521 Free PMC article.
Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers.
Terpos E, Trougakos IP, Karalis V, Ntanasis-Stathopoulos I, Gumeni S, Apostolakou F, Sklirou AD, Gavriatopoulou M, Skourti S, Kastritis E, Korompoki E, Papassotiriou I, Dimopoulos MA. Terpos E, et al. Among authors: apostolakou f. Cells. 2021 Jul 30;10(8):1942. doi: 10.3390/cells10081942. Cells. 2021. PMID: 34440710 Free PMC article.
Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece.
Terpos E, Karalis V, Sklirou AD, Apostolakou F, Ntanasis-Stathopoulos I, Bagratuni T, Iconomidou VA, Malandrakis P, Korompoki E, Papassotiriou I, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: apostolakou f. Am J Hematol. 2022 Apr;97(4):E147-E150. doi: 10.1002/ajh.26468. Epub 2022 Jan 25. Am J Hematol. 2022. PMID: 35025124 Free PMC article. No abstract available.
Immune response and adverse events after vaccination against SARS-CoV-2 in adult patients with transfusion-dependent thalassaemia.
Delaporta P, Terpos E, Solomou EE, Gumeni S, Nitsa E, Apostolakou F, Kyriakopoulou D, Ntanasis-Stathopoulos I, Papassotiriou I, Trougakos IP, Dimopoulos MA, Kattamis A. Delaporta P, et al. Among authors: apostolakou f. Br J Haematol. 2022 Jun;197(5):576-579. doi: 10.1111/bjh.18146. Epub 2022 Mar 14. Br J Haematol. 2022. PMID: 35286720 Free PMC article.
Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals.
Terpos E, Karalis V, Ntanasis-Stathopoulos I, Apostolakou F, Gumeni S, Gavriatopoulou M, Papadopoulos D, Malandrakis P, Papanagnou ED, Korompoki E, Kastritis E, Papassotiriou I, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: apostolakou f. Hemasphere. 2021 Dec 17;6(1):e677. doi: 10.1097/HS9.0000000000000677. eCollection 2022 Jan. Hemasphere. 2021. PMID: 34938959 Free PMC article.
Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis.
Kastritis E, Papassotiriou I, Merlini G, Milani P, Terpos E, Basset M, Akalestos A, Russo F, Psimenou E, Apostolakou F, Roussou M, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Fotiou D, Ziogas DC, Papadopoulou E, Pamboucas C, Dimopoulos MA, Palladini G. Kastritis E, et al. Among authors: apostolakou f. Blood. 2018 Apr 5;131(14):1568-1575. doi: 10.1182/blood-2017-12-819904. Epub 2018 Jan 31. Blood. 2018. PMID: 29386197 Free article. Clinical Trial.
31 results